Gonadal dysfunction in adult men with congenital adrenal hyperplasia.
Two adult males are described with congenital adrenal hyperplasia (21-hydroxylase deficiency). Patient 1 was receiving therapy with cortisone acetate and presented with clinical features of glucocorticoid excess and uncontrolled adrenal androgen activity. It was established that the short-acting steroid which the patient was receiving was cleared so rapidly that endogenous ACTH secretion was not inhibited. Patient 2 presented with enlarged and painful testes in association with poor compliance with corticosteroid therapy. The histologic picture of the testis was compatible with 'Leydig cell hyperplasia'. However, successful response to dexamethasone therapy suggests that the testes harboured an adrenal rest. These observations highlight the need for careful follow-up and treatment of adult male patients with congenital adrenal hyperplasia.
D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D003907:Dexamethasone / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007985:Leydig Cells / Q000473:pathology; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011279:Pregnanetriol / Q000097:blood; D011284:Pregnenolone / Q000097:blood; D011374:Progesterone / Q000097:blood; D013737:Testis / Q000503:physiopathology*; D013739:Testosterone / Q000097:blood
D011279:Pregnanetriol; D013739:Testosterone; D011374:Progesterone; D011284:Pregnenolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone